A data tool that could aid the prediction of how glaucoma progresses is being developed to improve personalised care for patients.

The Moorfields Glaucoma BioResource, which has been jointly funded by Fight for Sight and Glaucoma UK, addressed the need to improve management of the disease by linking genetic and clinical data to predict its progression.

A team of researchers, led by ophthalmologist Dr Anthony Khawaja, hoped to develop prediction models to identify primary open-angle glaucoma patients at highest risk of progression and blindness.

‘There is an urgent need to improve care for glaucoma patients. The potential of a prediction model could be huge. We foresee the Glaucoma Bioresource will be a powerful enabler of translation to clinical benefit of multiple streams of genetics research. We eagerly await the outcomes of the project,’ Dr Khawaja said.